181 related articles for article (PubMed ID: 31345635)
1. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
Jeong CW; Cowan JE; Broering JM; Ten Ham RMT; Wilson LS; Carroll PR; Cooperberg MR
Eur Urol; 2019 Dec; 76(6):743-751. PubMed ID: 31345635
[TBL] [Abstract][Full Text] [Related]
2. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
3. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.
Krahn MD; Bremner KE; Alibhai SM; Ni A; Tomlinson G; Laporte A; Naglie G
Qual Life Res; 2013 Dec; 22(10):2951-62. PubMed ID: 23564620
[TBL] [Abstract][Full Text] [Related]
4. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
Herlemann A; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2018 Feb; 73(2):215-223. PubMed ID: 28499617
[TBL] [Abstract][Full Text] [Related]
5. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial and Functional Predictors of Mental Disorder among Prostate Cancer Survivors: Informing Survivorship Care Programs with Evidence-Based Knowledge.
Massoeurs L; Ilie G; Lawen T; MacDonald C; Bradley C; Vo JDC; Rutledge RDH
Curr Oncol; 2021 Oct; 28(5):3918-3931. PubMed ID: 34677252
[TBL] [Abstract][Full Text] [Related]
7. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
[TBL] [Abstract][Full Text] [Related]
8. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
Bremner KE; Mitsakakis N; Wilson L; Krahn MD
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
[TBL] [Abstract][Full Text] [Related]
9. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors.
Kurian CJ; Leader AE; Thong MSY; Keith SW; Zeigler-Johnson CM
BMC Public Health; 2018 Aug; 18(1):1060. PubMed ID: 30139347
[TBL] [Abstract][Full Text] [Related]
10. Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.
Darwish-Yassine M; Berenji M; Wing D; Copeland G; Demers RY; Garlinghouse C; Fagerlin A; Newth GE; Northouse L; Holmes-Rovner M; Rovner D; Sims J; Wei JT
J Cancer Surviv; 2014 Mar; 8(1):121-30. PubMed ID: 24214413
[TBL] [Abstract][Full Text] [Related]
11. Utilities for prostate cancer health states in men aged 60 and older.
Stewart ST; Lenert L; Bhatnagar V; Kaplan RM
Med Care; 2005 Apr; 43(4):347-55. PubMed ID: 15778638
[TBL] [Abstract][Full Text] [Related]
12. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.
Donnelly DW; Gavin A; Downing A; Hounsome L; Kearney T; McNair E; Allan D; Huws DW; Wright P; Selby PJ; Kind P; Watson E; Wagland R; Wilding S; Butcher H; Mottram R; Allen M; McSorley O; Sharp L; Mason MD; Cross WR; Catto JWF; Glaser AW
Eur Urol; 2019 Aug; 76(2):228-237. PubMed ID: 31060822
[TBL] [Abstract][Full Text] [Related]
13. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
[TBL] [Abstract][Full Text] [Related]
14. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
15. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry.
Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL
BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954
[TBL] [Abstract][Full Text] [Related]
16. Predictors of utilities for health states in early stage prostate cancer.
Saigal CS; Gornbein J; Nease R; Litwin MS
J Urol; 2001 Sep; 166(3):942-6. PubMed ID: 11490251
[TBL] [Abstract][Full Text] [Related]
17. Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
[TBL] [Abstract][Full Text] [Related]
18. Post-Treatment Adverse Health Correlates among Prostate Cancer Survivors in a Sample of Men Residing in Atlantic Canada.
Ilie G; Rutledge R; Sweeney E
Curr Oncol; 2021 Jul; 28(4):2812-2822. PubMed ID: 34436012
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Adam S; Feller A; Rohrmann S; Arndt V
Health Qual Life Outcomes; 2018 Jan; 16(1):22. PubMed ID: 29361950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
